chevron_leftBack
As of 14 June 2026, Tsubota Laboratory Inc. has a market cap of $47.86M USD, ranking #30881 globally and #2884 in Japan.
It ranks #7044 in the Industrials sector, and #825 in the Specialty Business Services industry.
Key Stats
Market Cap
$47.86MUSD
7.66B JPY
Enterprise Value
$40.9MUSD
6.55B JPY
Revenue (TTM)
$4.44MUSD
710.43M JPY
EBITDA (TTM)
-$2.32MUSD
-372.36M JPY
Net Income (TTM)
-$2.5MUSD
-399.54M JPY
PS Ratio
10.8
PB Ratio
6.9
Company Profile
Country (HQ)
Sector
Industrials
Industry
Specialty Business Services
CEO
Kazuo Tsubota
open_in_new
Employees
17
Founded
2012
Website
tsubota-lab.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -1.4% | -4.6% | -11% | -7.3% | -10% | -29% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
4890
株式会社 坪田ラボ
ISIN: JP3535700003
Shares Out.:
Shares Outstanding:
25.794M1
Shares Float:
7.114M2
|
293 JPY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Tsubota Laboratory Inc.
Tsubota Laboratory Incorporated engages in the development and sale of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, presbyopia, and neurological disorders. The company was incorporated in 2012 and is based in Tokyo, Japan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSE: 9735
|
$14.55B
30K%
2.33T JPY
|
22.1
|
|
NASDAQ: PAYP
|
$13.65B
28K%
|
17.5
|
|
TSE: 4523
|
$8.11B
17K%
1.3T JPY
|
30.4
|
|
TSE: 6532
|
$4.97B
10K%
795.87B JPY
|
21.0
|
|
TSE: 2331
|
$3.66B
8K%
585.61B JPY
|
17.4
|
|
TSE: 4194
|
$1.87B
4K%
300.04B JPY
|
17.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: SHOP
|
$158.14B
330K%
|
129.8
|
|
STO: VSURE
|
$132.68B
277K%
114.8B EUR
|
-
|
|
NASDAQ: CTAS
|
$69.6B
145K%
|
36.8
|
|
LSE: REL
|
$63.78B
133K%
47.6B GBP
|
23.9
|
|
NASDAQ: PYPL
|
$45.83B
96K%
|
9.4
|
|
|
T
NEO: TRI
|
$41.8B
87K%
56.91B CAD
|
-
|
chevron_leftBack